Trademark Overview
On Thursday, September 11, 2025, a trademark application was filed for LYCIA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the LYCIA THERAPEUTICS trademark a serial number of 99387673. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, January 23, 2026. This trademark is owned by Lycia Therapeutics, Inc.. The LYCIA THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations comprising small molecules and antibodies for degrading disease-causing cellular proteins for treatment of cancer, autoimmune diseases, immunologic-based diseases and other human diseases, in particular, neurological disorders and conditions; Pharmaceutical preparations for the prevention and treatment of cancer, autoimmune diseases, immunologic-based diseases and other human diseases, in particular, neurological disorders and conditions; Biological preparations for the prevention and treatment of cancer, autoimmune diseases, immunologic-based diseases and other human diseases, in particular, neurological disorders and conditions; Gene therapy products, namely, biological preparations for the treatment of cancer, autoimmune diseases, immunologic-based diseases and other human diseases, in particular, neurological disorders and conditions; Pharmaceutical preparations for use in gene therapy; Biological preparations for use in gene therapy; Viruses for therape...
